New Delhi, 31 March 2025: ENTOD Pharmaceuticals, in collaboration with the Matanand Welfare Foundation, successfully concluded its World Glaucoma Week 2025 campaign, held from March 9th to March 15th, 2025. The campaign focused on raising awareness about glaucoma and the importance of early detection, reaching over 2,000 doctors and 15,000 patients across India through free screenings, awareness programs, and educational initiatives.
In India, more than 10 million people have glaucoma, but over 90% don’t even know it because they don’t get regular eye check-ups. Glaucoma is a group of eye conditions that can slowly damage vision without warning. It happens when pressure builds up in the eye and corrodes the optic nerve. If not treated in time, it can lead to permanent blindness. Unfortunately, most people don’t notice any symptoms until it’s too late. Some may experience blurry vision, eye pain, headaches, or difficulty with peripheral vision but many don’t realize they have it until significant vision loss has already occurred. Early detection can help catch the signs at an earlier stage before the condition worsens. Glaucoma can be managed with medications, laser treatment, or surgery to control eye pressure and protect vision.
Nikkhil K Masurkar, CEO of ENTOD Pharmaceuticals, on the campaign’s impact, said “Our goal with this campaign was to spread awareness about Glaucoma, which is a major cause of blindness, and make screenings easier to access. The response shows how much this was needed. At ENTOD, we believe that the right information and timely care can save vision. That’s why we are working closely with doctors, hospitals, and communities to ensure more people get tested and treated in time.”
Mrs. Anjula Masurkar, Clinical Director of ENTOD Pharmaceuticals, added, “We are extremely proud of the impact we made during the World Glaucoma Week 2025 but at the same time we do recognize that we must continue these patient-centric awareness activities regularly throughout the year. Serving and making a positive difference in our community forms an integral part of our duty and responsibility as human beings”
With campaigns like World Glaucoma Week 2025, ENTOD aims to expand its efforts to reach out more people, strengthen collaborations with medical professionals, and develop better ways to improve glaucoma detection and treatment. The company is committed to making glaucoma awareness an ongoing, year-round effort rather than a one-time initiative.
World Glaucoma Week 2025 marks another milestone in ENTOD Pharmaceuticals’ ongoing efforts to promote better vision care. With this momentum, the company is already looking forward to World Glaucoma Week 2026 and plans to further expand its reach and impact.